Stryker | SYK - Ebitda


Stryker reported $1.83B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
AtriCure USD 26.8M 480K Sep/2026
Baxter International USD 474M 165M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
CONMED USD 67.88M 10.24M Sep/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Danaher USD 2.1B 257M Sep/2026
Dexcom USD 435.2M 46.5M Sep/2026
Edwards Lifesciences USD 562.2M 6.6M Jun/2026
Globus Medical USD 262.21M 17.63M Sep/2026
Haemonetics USD 111.41M 15.25M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Integra LifeSciences USD 79.79M 1.37M Sep/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
J&J USD 8.99B 721M Jun/2026
Medtronic USD 2.63B 174M Jun/2026
Merit Medical Systems USD 103.93M 461K Sep/2026
Olympus JPY 74.16B 27.9B Sep/2026
Smith & Nephew USD 796M 139M Dec/2025
Steris USD 413.1M 29.9M Jun/2026
Stryker USD 1.83B 102M Sep/2026
Tandem Diabetes Care USD 18.04M 11.62M Sep/2026
Teleflex USD 122.91M 47.28M Jun/2026
Terumo JPY 8.62B 108.05B Sep/2026
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026